Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases

por Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Publicado 2012

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

por Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Hrušková, Zdenka, Svobodová, Barbora, Machková, Naděžda, Komárek, Viktor, Fučíková, Terezie, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Publicado 2011

Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers

por Malíčková, Karin, Francová, Irena, Lukáš, Milan, Kolář, Martin, Králíková, Eva, Bortlík, Martin, Ďuricová, Dana, Štěpánková, Lenka, Zvolská, Kamila, Pánková, Alexandra, Zima, Tomáš
Publicado 2017

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study

por Mitrova, Katarina, Pipek, Barbora, Bortlik, Martin, Bouchner, Ludek, Brezina, Jan, Douda, Tomas, Drasar, Tomas, Drastich, Pavel, Falt, Premysl, Klvana, Pavel, Leksa, Vaclav, Novotny, Ales, Svoboda, Pavel, Skorpik, Jan, Ulbrych, Jan, Veinfurt, Marek, Zborilova, Blanka, Lukas, Milan, Duricova, Dana
Publicado 2021